FCGR3A and neoplasm: Indeed, CD16-triggered ADCC and phagocytosis, performed by NK cells and macrophages, respectively, are among the main immune-dependent mechanisms by which therapeutic monoclonal antibodies (mAbs) mediate tumor cell killing (24–27).